Home > Newsletters > International Pharmaceutical Regulatory Monitor > Inspection of Pacira Plant Prompts EU Recall of Cancer Drug DepoCyte
International Pharmaceutical Regulatory Monitor
September 2012 | Vol. 40 No. 9
Inspection of Pacira Plant Prompts EU Recall of Cancer Drug DepoCyte
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has urged Pacira Pharmaceuticals’ cancer drug DepoCyte be recalled in certain EU countries, citing “manufacturing deficiencies” found at the company’s San Diego, Calif., facility.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.